Officials at Autolomous and Cellular Origins say the companies have carried out the end-to-end integration of their respective platforms to bring full automation and digitization to the entire cell ...

The development agreement will see Fresenius Kabi's cell therapy processing technologies integrated into Cellular Origins' robotic platform. Credit: Kotin/Shutterstock. · Pharmaceutical Technology · ...

CAMBRIDGE, England & BAD HOMBURG, Germany--(BUSINESS WIRE)--Cellular Origins and Fresenius Kabi, an operating company of Fresenius, announce today they have signed a development agreement that ...

Autolomous and Cellular Origins today announce end-to-end integration of their respective platforms, bringing full automation and digitization to the entire cell therapy manufacturing process. This ...

Cellular Origins reports that the company completed the first phase of its collaboration with Fresenius Kabi designed to help scale the manufacturing of cell and gene therapies using advanced robotics ...

Cellular Origins and Fresenius Kabi, an operating company of Fresenius, announce today they have signed a development agreement that leverages each company’s expertise in cell and gene therapies (CGTs ...